Junqing Cui

5.1k total citations · 2 hit papers
14 papers, 4.4k citations indexed

About

Junqing Cui is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Junqing Cui has authored 14 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Junqing Cui's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Immune Response and Inflammation (4 papers). Junqing Cui is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Immune Response and Inflammation (4 papers). Junqing Cui collaborates with scholars based in Japan, United States and Canada. Junqing Cui's co-authors include Tetsu Kawano, Masaru Taniguchi, Haruhiko Koseki, Eisuke Kondo, Hiroshi Sato, Isao Toura, Yoshikatsu Kaneko, Yasuhiko Koezuka, Kazuhiro Motoki and Hitomi Ueno and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Junqing Cui

14 papers receiving 4.4k citations

Hit Papers

CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT... 1997 2026 2006 2016 1997 1997 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
    1997 2.1k citations Tetsu Kawano, Junqing Cui et al. Science profile →
  2. Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
    1997 1.1k citations Junqing Cui, Tahiro Shin et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junqing Cui Japan 13 3.8k 979 675 294 200 14 4.4k
Kazuhiro Motoki Japan 21 3.5k 0.9× 769 0.8× 954 1.4× 299 1.0× 95 0.5× 41 4.2k
Marko Pesu Finland 26 1.3k 0.3× 1.0k 1.1× 822 1.2× 272 0.9× 122 0.6× 62 3.1k
Jane S.A. Voerman Netherlands 19 2.3k 0.6× 503 0.5× 670 1.0× 192 0.7× 433 2.2× 35 3.3k
Raelene J. Grumont Australia 34 3.4k 0.9× 978 1.0× 1.7k 2.6× 322 1.1× 111 0.6× 59 5.1k
Kenneth Schooley United States 10 1.5k 0.4× 913 0.9× 1.3k 2.0× 308 1.0× 257 1.3× 12 3.6k
T D Geppert United States 24 1.7k 0.4× 680 0.7× 1.3k 1.9× 168 0.6× 98 0.5× 35 3.2k
Jian‐Zhong Qin United States 26 1.6k 0.4× 597 0.6× 1.1k 1.6× 273 0.9× 308 1.5× 43 3.3k
Shuhua Han United States 30 2.2k 0.6× 522 0.5× 910 1.3× 322 1.1× 154 0.8× 82 3.6k
Richard V. Parry United Kingdom 23 3.0k 0.8× 2.2k 2.3× 1.3k 1.9× 290 1.0× 133 0.7× 32 4.6k
Raymond Davis United States 9 967 0.3× 1.1k 1.1× 1.4k 2.1× 276 0.9× 277 1.4× 12 3.5k

Countries citing papers authored by Junqing Cui

Since Specialization
Citations

This map shows the geographic impact of Junqing Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqing Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqing Cui more than expected).

Fields of papers citing papers by Junqing Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqing Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqing Cui. The network helps show where Junqing Cui may publish in the future.

Co-authorship network of co-authors of Junqing Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Junqing Cui. A scholar is included among the top collaborators of Junqing Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqing Cui. Junqing Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wu, Junjun, Neal Green, Rajeev Hotchandani, et al.. (2009). Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-α production in human whole blood. Bioorganic & Medicinal Chemistry Letters. 19(13). 3485–3488. 36 indexed citations
2.
Ci, Xinxin, Yu Song, Fanqin Zeng, et al.. (2008). Ceftiofur impairs pro-inflammatory cytokine secretion through the inhibition of the activation of NF-κB and MAPK. Biochemical and Biophysical Research Communications. 372(1). 73–77. 27 indexed citations
3.
An, Na, Xuemei Zhang, Xinxin Ci, et al.. (2008). Pretreatment of Mice with Rifampicin Prolongs Survival of Endotoxic Shock by Modulating the Levels of Inflammatory Cytokines. Immunopharmacology and Immunotoxicology. 30(3). 437–446. 12 indexed citations
4.
Marušić, Suzana, Paresh Thakker, Jeffrey W. Pelker, et al.. (2008). Blockade of cytosolic phospholipase A2α prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses. Journal of Neuroimmunology. 204(1-2). 29–37. 51 indexed citations
5.
Huang, Adrian, Diane Joseph‐McCarthy, Frank Lovering, et al.. (2007). Structure-based design of TACE selective inhibitors: Manipulations in the S1′–S3′ pocket. Bioorganic & Medicinal Chemistry. 15(18). 6170–6181. 24 indexed citations
6.
Carter, Laura, Michael W. Leach, Mihai L. Azoitei, et al.. (2006). PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 182(1-2). 124–134. 156 indexed citations
7.
Marušić, Suzana, Michael W. Leach, Jeffrey W. Pelker, et al.. (2005). Cytosolic phospholipase A2α–deficient mice are resistant to experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 202(6). 841–851. 123 indexed citations
8.
Cui, Junqing, Joy Miyashiro, Paresh Thakker, et al.. (2005). TH1-mediated airway hyperresponsiveness independent of neutrophilic inflammation. Journal of Allergy and Clinical Immunology. 115(2). 309–315. 56 indexed citations
9.
Widlund, Hans R., Martin A. Horstmann, Edwin R. Price, et al.. (2002). β-Catenin–induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor. The Journal of Cell Biology. 158(6). 1079–1087. 221 indexed citations
10.
Nakayama, Toshinori, Masakatsu Yamashita, Tetsu Kawano, et al.. (2001). The Role of α-Galactosylceramide-Activated Vα14 Natural Killer T Cells in the Regulation of Th2 Cell Differentiation. International Archives of Allergy and Immunology. 124(1-3). 38–42. 2 indexed citations
11.
Cui, Junqing, Naohiro Watanabe, Tetsu Kawano, et al.. (1999). Inhibition of T Helper Cell Type 2 Cell Differentiation and Immunoglobulin E Response by Ligand-Activated Vα14 Natural Killer T Cells. The Journal of Experimental Medicine. 190(6). 783–792. 143 indexed citations
12.
Kawano, Tetsu, Junqing Cui, Yasuhiko Koezuka, et al.. (1998). Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proceedings of the National Academy of Sciences. 95(10). 5690–5693. 419 indexed citations
13.
Cui, Junqing, Tahiro Shin, Tetsu Kawano, et al.. (1997). Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors. Science. 278(5343). 1623–1626. 1089 indexed citations breakdown →
14.
Kawano, Tetsu, Junqing Cui, Yasuhiko Koezuka, et al.. (1997). CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides. Science. 278(5343). 1626–1629. 2066 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiro Motoki Breakdown of academic impact, for papers by Marko Pesu Breakdown of academic impact, for papers by Jane S.A. Voerman Breakdown of academic impact, for papers by Raelene J. Grumont Breakdown of academic impact, for papers by Kenneth Schooley Breakdown of academic impact, for papers by T D Geppert Breakdown of academic impact, for papers by Jian‐Zhong Qin Breakdown of academic impact, for papers by Shuhua Han Breakdown of academic impact, for papers by Richard V. Parry Breakdown of academic impact, for papers by Raymond Davis
Rankless by CCL
2026